期刊文献+

2型糖尿病肾病患者血清脂联素、血管内皮生长因子水平与氧化应激的相关性 被引量:13

Association of Serum Adiponection and Vascular Endothelial Growth Factors with Oxidative Stress in Type 2 Diabetic Nephropathy
原文传递
导出
摘要 目的:探讨2型糖尿病肾病(DN)不同阶段血清脂联素(APN)、血管内皮生长因子(VEGF)变化及其与氧化应激的关系。方法:将符合1999年WHO诊断标准的2型糖尿病患者根据24h尿蛋白排泄率分为3组,即正常白蛋白尿组(SDM)、微量白蛋白尿组(NA)、大量蛋白尿组(MA)。另设正常对照组(NC)。采用双抗夹心ELISA法检测DN患者血清APN、VEGF水平,采用比色法测定超氧化物歧化酶(SOD)活性及丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)含量。结果:①DN患者血清APN水平低于正常对照组;DN患者各组间比较,大量蛋白尿组的血清APN水平最低,差异有统计学意义(P<0.05);血清VEGF水平在NA、MA组明显高于SDM组和NC组,差异有统计学意义(P<0.05)。②与NC组比较,SOD活性及GSH-Px水平在糖尿病各组明显下降(P<0.01),MDA水平在NA组、MA组明显升高(P<0.01)。③糖尿病患者血清APN与UAER、MDA、VEGF浓度呈负相关(P<0.05),与SOD、GSH-Px呈显著正相关(P<0.01);血清VEGF浓度与病程、HbA1c、UAER、MDA的升高呈正相关(P<0.05),与SOD、GSH-Px呈显著负相关(P<0.01)。结论:DN患者血清APN、VEGF水平与氧化应激密切相关,低APN血症是2型糖尿病及DN发生的危险因素,VEGF升高可能是DN的危险因素。 Objective: To investigate the association of serum adiponection(APN) and vascular endothelial growth factors(VEGF) with oxidative stress in different stages of diabetic nephropathy.Methods: Twenty-five healthy subjects(NC) and 105 patients with type 2 diabetes mellitus,which were sub-divided into three groups according to their uriary albumin excretion rate(UAER) as: normal UAER group(SDM group,n=35),microalbuminuria group(NA group,n=35),and clinical proteinuria group(MA group,n=35).Serum APN and VEGF were measured by ELISA,and superoxide dismutase(SOD),serum malondialdehyde(MDA) and glutathione peroxidase(GSH-Px) were determined by chemical chromatometry.Results: ①The level of serum APN was lower in diabetic nephropathy patients than in NC group(P0.05).Among diabetic patients,the serum APN in MA group was significantly lower than that in SDM and NA groups(P0.05);the serum VEGF in NA and MA groups were significantly higher than that in NC and SDM groups(P0.05).②As compare with that respectively in NC group,the activity of SOD and serum GSH-Px level in the three diabetic groups were significantly lower(P0.01).Serum MDA level was increased significantly in NA and MA groups(P0.01).③For the patients,serum APN was negatively correlated with UAER,MDA,and VEGF(P0.05),and positively correlated with SOD and GSH-Px(P0.01).Serum VEGF was positively correlated with duration of disease,HbA1c,UAER,and MDA(P0.05),and negatively correlated with SOD and GSH-Px(P0.01).Conclusion: In patients with diabetic nephropathy,serum APN and VEGF were correlated with SOD and other oxidative stress indices.Lower serum APN was a risk factor to diabetes and diabetic nephropathy,while elevated VEGF may be a risk factor of the onset of diabetic nephropathy.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2012年第2期228-231,234,共5页 Medical Journal of Wuhan University
关键词 糖尿病肾病 脂联素 血管内皮生长因子 氧化应激 Diabetic Nephropathy Adiponection Vascular Endothelial Growth Factors Oxidative Stress
  • 相关文献

参考文献14

  • 1Takebayashi K,Matsumoto S,Aso Y,et al.Aldoste-rone blockade attenuatesurinary monocyte chemoattrac-tant protein-1and oxidative stress in patients with type2diabetes complicated by diabetic nephropathy[J].JClin Endocrinol Metab,2006,91(60):2 214-2 217.
  • 2Cha DR,Kang YS,Han SY,et al.Vascular endothe-lial growth factor is increased during early stage of dia-betic nephropathy in typeⅡdiabetic rats[J].J Endo-crinol,2004,183(1):183-194.
  • 3Takashi K,Toshimasa Y.Adiponectin and adiponectinreceptors[J].End Rev,2005,26(3):439-451.
  • 4Yilamz MI,Saglam M,Qureshi AR,et al.Endothelialdysfunction in type-2diabetics with early diabetic ne-phropathy is associated with low circulating adiponectin[J].Nephrol Dial Transplant,2008,2(5):1 621-1 627.
  • 5潘云龙,朱妍,王晓玲,程英英,张真稳,王艳,陈晖.2型糖尿病患者血浆脂联素浓度改变及其与胰岛素抵抗的关系[J].实用临床医药杂志,2004,8(4):19-21. 被引量:21
  • 6Motoshima H,Wu X,Mahadev K,et al.Adiponectinsuppresses proliferation an superoxide generation andenhancesEnos activity in endothelial cells treated withoxidized LDL[J].Biochem Biophs Res Commun,2004,315:264-271.
  • 7Hattori S,Hattori Y,Kasai K.Hypoadiponectinemiais caused by chronic Blockade of nitric oxide synthesisin rats[J].Metabolism,2005,54(4):482.
  • 8Katsuki A,Suematsu M,Gabazza EC,et al.Increasedoxidative stress is associated with decreased with de-creased circulating levels of adiponetin in Japanese metabol-ically obese,normal-weight men with normal glucose toler-ance[J].Diabetes Res Clin Pract,2006,73:31.
  • 9李红,郑芬萍,张哲.糖尿病大鼠外周血单个核细胞内与肾皮质中TGF-β_1mRNA水平的相关性研究[J].浙江大学学报(医学版),2004,33(1):51-54. 被引量:9
  • 10Cha DR,Kang YS,Han SY,et al.Vascular endothe-lial growth factor is increased during early stage of dia-betic nephropathy in typeⅡdiabetic rats[J]. J Endo-crinol,2004,183(1):183-194.

二级参考文献34

  • 1Yoda Murakami M, Taniguchi M, Takahashi K, et al. Chang in expression of GB28/adiponectin in carbon tetrachloride administrated mouse liver.Biochem Biophys Res Commun, 2001, 285: 372.
  • 2Nakano Y, Tobe T, Choi-Miura N H, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma[J]. J Biochem, 1996, 120: 803.
  • 3Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J]. Nat Med, 2001, 7: 941.
  • 4Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity[J]. J Biol Chem. 1996 May 3, 271(18): 10697.
  • 5Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J]. Biochem Biophys Res Commun. 1999 Apr 2, 257(1): 79.
  • 6Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients[J]. Arterioscler Thromb Vasc Biol. 2000 Jun, 20(6): 1595.
  • 7Hotta K, Funahashi T, Bodkin N L, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys[J]. Diabetes, 2001 May, 50(5): 1126.
  • 8Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population[J]. Clin Sci (Lond). 2002 Aug, 103(2): 137.
  • 9Yang W S, Jeng C Y, Wu T J, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients[J]. Diabetes Care. 2002 Feb, 25(2): 376.
  • 10Michael S, Otto T, Andreas F, et al. Association of the T-G Polymorphism in Adiponectin (Exon 2) With Obesity and Insulin Sensitivity Diabetes, 2002, 51: 37.

共引文献29

同被引文献194

引证文献13

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部